Inhibitor Therapeutics, Inc. (INTI) SEC Filings & Financial Intelligence
Inhibitor Therapeutics, Inc. (INTI) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INTI
CIK: 1042418
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Cherry Bekaert LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerChristopher Rux
Audit LocationTampa, Florida, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-18 | 2026-09-15 | 8-K | 0001493152-26-043331 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-17 | 2026-08-17 | DEF 14A | 0001493152-26-038636 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038288 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-01 | 4 | 0001493152-26-036080 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-05-04 | 4 | 0001493152-26-035962 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-05-04 | 4 | 0001493152-26-035955 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-05-04 | 4 | 0001493152-26-035953 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-05-04 | 4 | 0001493152-26-035950 | View SEC Doc Filr Page |
| 4 | 2026-06-24 | 2026-05-04 | 4 | 0001493152-26-029898 | View SEC Doc Filr Page |
| 4 | 2026-06-01 | 2026-05-05 | 4 | 0001493152-26-026623 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023622 | View SEC Doc Filr Page |
| 8-K | 2026-04-01 | 2026-04-01 | 8-K | 0001493152-26-014637 | View SEC Doc Filr Page |
| 8-K | 2026-04-01 | 2026-04-01 | 8-K | 0001493152-26-014517 | View SEC Doc Filr Page |
| 10-K | 2026-03-26 | 2025-12-31 | 10-K | 0001493152-26-012751 | View SEC Doc Filr Page |
| 8-K | 2026-02-24 | 2026-02-24 | 8-K | 0001493152-26-007821 | View SEC Doc Filr Page |
| 10-Q | 2025-11-13 | 2025-09-30 | 10-Q | 0001493152-25-022178 | View SEC Doc Filr Page |
| 8-K | 2025-10-27 | 2025-10-24 | 8-K | 0001493152-25-019381 | View SEC Doc Filr Page |
| UPLOAD | 2025-09-15 | — | UPLOAD Filing | 0000000000-25-009975 | View SEC Doc Filr Page |
| 10-Q | 2025-08-13 | 2025-06-30 | 10-Q | 0001641172-25-023465 | View SEC Doc Filr Page |
| CORRESP | 2025-07-22 | — | CORRESP Filing | 0001641172-25-020608 | View SEC Doc Filr Page |
| UPLOAD | 2025-07-17 | — | UPLOAD Filing | 0000000000-25-007569 | View SEC Doc Filr Page |
| 10-Q | 2025-05-14 | 2025-03-31 | 10-Q | 0001641172-25-010110 | View SEC Doc Filr Page |
| 4 | 2025-04-10 | 2024-04-01 | 4 Filing | 0001641172-25-003556 | View SEC Doc Filr Page |
| 4 | 2025-04-07 | 2024-04-01 | 4 Filing | 0001641172-25-003033 | View SEC Doc Filr Page |
| 4 | 2025-04-07 | 2024-04-01 | 4 Filing | 0001641172-25-003029 | View SEC Doc Filr Page |